Exploring copper-diimine coordination compounds as promising alternatives to traditional platinum-based cancer treatments with enhanced selectivity and reduced side effects.
Explore how astatine-211, a rare radioactive element, is revolutionizing targeted alpha therapy for cancer treatment with its precise cell-destroying capabilities.
Explore how coordination, organometallic and supramolecular chemistry are transforming metal-based cancer therapies from cisplatin to advanced metallacages.
Explore the groundbreaking discovery of PF-3758309, a potent PAK4 inhibitor that targets cancer at its molecular roots through innovative drug design and validation.
Discover how scientists use click chemistry to conjugate Anti-HER2 antibodies to nanoparticles for targeted cancer therapy
Discover how pH-responsive hollow mesoporous silica nanoparticles are creating a new frontier in targeted cancer therapy by exploiting tumor acidity.
Explore Russia's pioneering role in Boron Neutron Capture Therapy (BNCT) - a revolutionary cancer treatment that targets malignant cells with atomic precision.
Explore how yttrium-90, derived from strontium-90 nuclear waste, is transforming cancer treatment through innovative separation techniques and medical applications.
Explore the revolutionary science behind Aurora kinase inhibitors and how targeting cellular division is reshaping cancer therapy with patented innovations.
Explore the revolutionary advancements in next-generation antibody-drug conjugates (ADCs) for cancer therapy, including bispecific ADCs, novel payloads, and AI-driven development.